XM does not provide services to residents of the United States of America.

FX options wrap - Falling FX volatility precedes a resurgence



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>BUZZ-FX options wrap - Falling FX volatility precedes a resurgence</title></head><body>

Price action in FX options suggests traders are anticipating a period of lower FX volatility before a resurgence in early November.

Implied volatility for options expiring through the end of October is relatively low and sellers have been dominating the fairly limited trade flows. However, benchmark 1-month expiry options include the U.S. NFP data, U.S. election results and the U.S. policy decision in early November, where related FX volatility risk premiums are significantly higher.

Benchmark 1-month expiry EUR/USD risk reversals post their highest downside strike implied volatility premiums since early July at 0.4, which shows the most vulnerable side of that pairing. However, EUR/USD downside is potentially limited to the middle of the longer term range around 1.0800. There's been similar price action in GBP/USD with its 1-month risk reversals reaching new recent highs for GBP puts over calls at 0.5.

USD/JPY 1-month implied volatility has retraced its post U.S. election inclusion spike from 12.5 to 13.75 and would suggest potential value when compared to its 1-month historic volatility measure at 13.2. Barriers at 150.00 remain intact below some key technical resistance levels.

USD/CNH options are looking to Saturday's stimulus announcement as a potential volatility/directional catalyst, but there's been more demand for post US. election dates, which has driven the 1-month USD/CNH implied volatility to new highs since Dec 2022 above 8.0.



For more click on FXBUZ


USD/JPY FXO 1-month expiry implied vs historic volatility https://tmsnrt.rs/4h2pw3i

USD/CNH 1wk, 1-month and 3-month expiry FXO implied volatility https://tmsnrt.rs/3NhwnZf

EUR/USD benchmark 1-month expiry 25 delta risk reversals https://tmsnrt.rs/4dGcntR

(Richard Pace is a Reuters market analyst. The views expressed are his own)

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.